pEOpLE pROfILE | RobERT DAnIEls |
daniels elastagen
robert
Aesthetic medicine is a continually developing field, with a number of companies offering novel approaches to treatment. Rosalind Hill speaks to Robert Daniels, CEO of Elastagen.
hyaluronic acids. And after speaking to Robert Daniels, CEO of Elastagen, it would seem that the big breakthrough has finally come. Elastagen is an Australian-based
I 60 ❚
company pioneering technologies to repair and augment the skin using elastin. Elastin is an essential protein in human connective tissue that is responsible for the elasticity of the skin. It is able to stretch and recoil back to its original position, as seen, for example, in the lungs on inhalation and exhalation, or in the skin when making facial expressions.
n An InDustRy As fAst-pACED as aesthetic medicine and dermatology, perhaps it was only a matter of time until a product was developed to rival the botulinum toxins and
The break down of the skin's elastic
fibres is a hallmark of ageing, and represents an obvious starting point for skin repair. 'If we take a step back and consider
why you would want an intervention for the skin with elastin-based products, then it quickly becomes clear,' says Robert. 'During foetal development and soon
after birth, the majority of elastin that the body will have for a lifetime is produced, and after that the body has limited capacity to regenerate elastin following damage; this, coupled with people living for longer and sun damage, results in our skin losing its elasticity as we age.' 'A cause of skin ageing is the
degeneration of elastic fibres in the skin,' continues Robert.
October 2011 |
prime-journal.com 'What we are trying to achieve in
repairing aged or damaged skin is based on the premise that it is better to treat humans with products specifically designed for humans, in our case a synthetic human elastin. This is a different mindset to the use of other treatments (e.g. animal-based collagen, hyaluronic acid).
Research challenges The development of Elastagen and its research into elastin-based products offers a novel approach for the future of aesthetic medicine. While the majority of people may conjure up images of over-treatment and the 'frozen' face when they think of aesthetic treatments, newer products take the industry and its patients to a much more natural end
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84